Revived TranS1 Rebuilds Exec Team With New Sales VP
This article was originally published in Clinica
Executive Summary
TranS1, which has emerged from the ashes after its previous incarnation Baxano filed for bankruptcy last year, has appointed John Miller Vice-President of Sales. Miller\, joins from Boston firm SpineFrontier but previously served a stint with Baxano before. He will oversee the commercialization of AxiaLIF, the axial lumbar interbody fusion system that allows less invasive restabilization of the spine. TranS1 was restructured under new ownership earlier this year; it had merged with Baxano in 2013 and the combined entity was renamed Baxano. However the company ran into financial trouble, and filed for bankruptcy in November last year. Aside from Miller, the other two members of TranS1’s new executive team have a legal background. President and CEO Jeffrey Schell is a patent attorney by training, and the Executive VP and General Counsel is said to “have a track record as a successful litigator”.